No definition available.
Other and unspecified disorders of adult personality and behaviour
DOID EFO Endpoint Browser PheWeb
F5_PERSOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
219 |
4. Check minimum number of eventsNone |
219 |
5. Include endpointsNone |
219 |
6. Filter based on genotype QC (FinnGen only) |
219 |
Control definitions (FinnGen only)
- Control exclude
- F5_PERSOBEH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified disorders of adult personality and behaviour
based on the number of shared cases.
Similar with more cases:
- Disorders of adult personality and behaviour
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2012 | 998 | 1001 |
| Only index persons | 1845 | 947 | 898 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 30.95 | 30.95 | 30.80 |
| Only index persons | 29.81 | 29.99 | 29.62 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 219 | 146 | 73 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | 34.26 | 32.63 | 37.52 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 200
- Matched controls
- 1998
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F69
ICD-10 Finland
Unspecified disorder of adult personality and behaviour
+∞
132.5
112
*
N05AH04
ATC
quetiapine; oral
13.1
54.8
117
194
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
44.1
52.1
64
21
T36
ICD-10 Finland
Poisoning by systemic antibiotics
31.0
51.8
70
34
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
263.9
42.7
42
*
F60.9
ICD-10 Finland
Personality disorder, unspecified
+∞
41.1
38
*
F61.0
ICD-10 Finland
Mixed personality disorders
248.2
40.4
40
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
10.2
40.4
93
157
F68.1
ICD-10 Finland
Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]
+∞
39.9
37
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
15.2
39.9
70
68
F68.8
ICD-10 Finland
Other specified disorders of adult personality and behaviour
+∞
38.8
36
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
12.0
38.0
76
97
N05AH03
ATC
olanzapine; systemic
15.7
37.3
64
58
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
430.7
37.3
36
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
13.4
36.5
68
74
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
10.6
36.3
78
113
N06AX11
ATC
mirtazapine; oral
7.1
35.6
121
356
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
18.1
35.6
57
43
N03AG01
ATC
valproic acid; systemic, rectal
15.0
35.5
62
58
N05AA02
ATC
levomepromazine; systemic
35.8
35.2
45
16
N03AX09
ATC
lamotrigine; oral
18.5
34.7
55
40
N05BA01
ATC
diazepam; systemic, rectal
9.5
31.6
72
112
N06AX16
ATC
venlafaxine; oral
7.9
30.6
81
159
N05AX08
ATC
risperidone; systemic
14.0
29.9
53
50
N06AB06
ATC
sertraline; oral
8.4
27.3
66
110
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
15.8
27.0
45
36
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
12.4
26.8
50
52
F29
ICD-10 Finland
Unspecified nonorganic psychosis
14.2
26.4
46
41
N05AB03
ATC
perphenazine; systemic, rectal
27.9
25.8
35
15
N06AB04
ATC
citalopram; systemic
5.9
24.6
82
210
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
+∞
24.5
23
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
11.0
23.8
47
54
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
26.9
23.5
32
14
F68.0
ICD-10 Finland
Elaboration of physical symptoms for psychological reasons
+∞
23.4
22
*
N05BA04
ATC
oxazepam; oral
5.2
23.3
90
270
N05CF01
ATC
zopiclone; oral
5.1
23.3
94
296
N05AX12
ATC
aripiprazole; systemic
13.0
23.3
42
40
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
7.9
23.1
57
96
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
6.9
22.8
63
125
N03AE01
ATC
clonazepam; systemic
12.6
22.4
41
40
N03AX16
ATC
pregabalin; oral
5.1
20.4
76
214
N06AB03
ATC
fluoxetine; oral
6.2
19.9
59
126
N05AF03
ATC
chlorprothixene; systemic
19.4
19.9
30
18
P29
ICPC
Psychological sympt/compl other
7.9
19.8
48
77
N06AX03
ATC
mianserin; oral
20.9
19.8
29
16
P99
ICPC
Psychological disorders other
14.9
19.8
33
26
N05AD01
ATC
haloperidol; systemic
38.6
19.4
24
7
F99
ICD-10 Finland
Mental disorder, not otherwise specified
17.4
19.2
30
20
F31.8
ICD-10 Finland
Other bipolar affective disorders
25.7
18.3
25
11
ZY010
NOMESCO Finland
Hospital outpatient
9.2
18.2
39
51
F60.8
ICD-10 Finland
Other specific personality disorders
+∞
18.0
17
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
9.7
17.4
36
44
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
16.1
17.4
28
20
N05BE01
ATC
buspirone; oral
17.1
17.2
27
18
N06AX12
ATC
bupropion; oral
7.3
17.2
43
72
N05CD07
ATC
temazepam; oral
7.8
17.1
41
64
N05BA06
ATC
lorazepam; systemic, sublingual
13.4
16.7
29
25
C07AA05
ATC
propranolol; systemic
4.2
16.4
73
238
N03AF02
ATC
oxcarbazepine; oral
14.7
16.2
27
21
P80
ICPC
Personality disorder
172.9
15.7
16
*
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
14.7
15.7
26
20
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
18.0
15.7
24
15
N07BB01
ATC
disulfiram; oral
8.3
15.4
35
50
N06AB10
ATC
escitalopram; oral
3.8
15.4
81
301
P76
ICPC
Depressive disorder
6.8
15.3
40
71
F39
ICD-10 Finland
Unspecified mood [affective] disorder
18.4
15.2
23
14
F20.9
ICD-10 Finland
Schizophrenia, unspecified
18.4
15.2
23
14
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
18.4
15.2
23
14
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
7.3
15.0
37
60
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
4.4
15.0
61
180
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
14.1
14.9
25
20
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
18.8
14.7
22
13
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
7.5
14.5
35
55
N05AH02
ATC
clozapine; systemic
16.1
14.5
23
16
N06AA09
ATC
amitriptyline; systemic
9.3
14.4
30
37
P01
ICPC
Feeling anxious/nervous/tense
4.2
14.4
62
193
F90.0
ICD-10 Finland
Disturbance of activity and attention
9.8
14.3
29
34
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
19.4
14.2
21
12
P74
ICPC
Anxiety disorder/anxiety state
9.5
14.1
29
35
TPH04
NOMESCO Finland
Cathetrisation of vein
4.3
14.1
58
172
F10.25
ICD-10 Finland
Alcohol dependence continuous use
26.0
14.1
19
8
Z2446
NOMESCO Finland
Social worker
7.9
13.8
32
47
S06.0
ICD-10 Finland
Concussion
5.2
13.5
44
102
N05AN01
ATC
lithium; oral
13.5
13.5
23
19
Z2445
NOMESCO Finland
Psychologist
9.6
13.3
27
32
N06AB05
ATC
paroxetine; oral
6.5
13.2
35
63
M54.5
ICD-10 Finland
Low back pain
3.2
13.1
89
396
R56.8
ICD-10 Finland
Other and unspecified convulsions
7.8
13.0
30
44
AA1AD
NOMESCO Finland
CT of head and brain
4.0
12.9
57
179
A06AD11
ATC
lactulose; oral
5.9
12.8
37
74
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
12.8
12.7
22
19
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
7.9
12.7
29
42
N03AX12
ATC
gabapentin; oral
4.4
12.4
49
138
N05BA12
ATC
alprazolam; oral
5.2
12.4
40
91
N06AX21
ATC
duloxetine; oral
4.7
12.4
44
112
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
8.9
12.3
26
33
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
19.6
12.3
18
10
ZY000
NOMESCO Finland
Hospital inpatient
23.0
12.2
17
8
F34.1
ICD-10 Finland
Dysthymia
9.9
12.1
24
27
N06AX05
ATC
trazodone; oral
12.9
12.1
21
18
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
16.0
12.1
19
13
L28
ICPC
Limited function/disability (L)
5.4
11.9
37
81
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
32.2
11.8
15
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.9
11.6
98
493
N02AA05
ATC
oxycodone; systemic
6.6
11.6
30
52
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.5
11.6
35
74
F10.20
ICD-10 Finland
Alcohol dependence currently independent
16.3
11.5
18
12
XF400
NOMESCO Finland
ECG with 12 standard connections
4.6
11.5
42
109
F33.8
ICD-10 Finland
Other recurrent depressive disorders
37.4
11.4
14
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
13.8
11.4
19
15
N03AX11
ATC
topiramate; oral
12.2
11.3
20
18
P72
ICPC
Schizophrenia
12.2
11.3
20
18
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
11.0
11.3
21
21
P03
ICPC
Feeling depressed
4.0
11.1
48
147
Z3231
NOMESCO Finland
Registered nurse
3.2
11.1
70
289
N05CD02
ATC
nitrazepam; oral
46.0
11.1
13
*
R06.0
ICD-10 Finland
Dyspnoea
3.5
11.0
58
208
N05BA02
ATC
chlordiazepoxide; systemic
29.9
10.9
14
5
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
29.9
10.9
14
5
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
23.0
10.9
15
7
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
15.3
10.7
17
12
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.7
10.6
50
164
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.1
10.6
34
77
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
13.0
10.6
18
15
F61
ICD-10 Finland
Mixed and other personality disorders
115.8
10.5
11
*
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
34.5
10.5
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
10.3
84
404
R05
ICPC
Cough
3.2
10.3
62
243
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
10.0
10.3
20
22
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
10.9
10.3
19
19
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.3
10.3
27
48
R21
ICPC
Throat symptom/complaint
3.0
10.2
75
336
J45.9
ICD-10 Finland
Asthma, unspecified
3.6
10.2
50
169
C03CA01
ATC
furosemide; systemic
4.1
10.1
41
118
R51.80
ICD-10 Finland
Headache
3.5
10.1
53
188
N03AF01
ATC
carbamazepine; oral, rectal
9.5
10.1
20
23
X78
ICD-10 Finland
Intentional self-harm by sharp object
21.4
9.9
14
7
Z01.8
ICD-10 Finland
Other specified special examinations
3.4
9.9
54
198
F10.09
ICD-10 Finland
Alcohol intoxication UNS
14.4
9.9
16
12
R55
ICD-10 Finland
Syncope and collapse
5.1
9.8
31
69
K59.09
ICD-10 Finland
Constipation, unspecified
9.9
9.8
19
21
IGY02
NOMESCO Finland
Psychiatric monitoring contact
9.9
9.8
19
21
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
12.3
9.8
17
15
M79.6
ICD-10 Finland
Pain in limb
2.7
9.7
85
425
L03
ICPC
Low back symptom/complaint
3.0
9.7
68
296
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.0
9.7
31
70
R11
ICD-10 Finland
Nausea and vomiting
5.0
9.7
31
70
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
16.1
9.7
15
10
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.6
9.7
34
85
N05AB01
ATC
dixyrazine; systemic
31.7
9.5
12
*
F10.24
ICD-10 Finland
Alcohol depence active use
23.0
9.5
13
6
N02AX02
ATC
tramadol; systemic, rectal
2.7
9.4
89
463
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
+∞
9.4
9
*
F60.0
ICD-10 Finland
Paranoid personality disorder
+∞
9.4
9
*
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
8.4
9.4
20
26
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.2
9.4
55
212
G43.9
ICD-10 Finland
Migraine, unspecified
4.8
9.3
31
73
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
4.7
9.3
32
78
F41.8
ICD-10 Finland
Other specified anxiety disorders
7.7
9.3
21
30
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.8
9.2
31
74
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.8
9.2
40
122
SPAT1254
SPAT
Administration of medicine
3.6
9.2
43
140
XF600
NOMESCO Finland
Bloodpressure measurement
6.5
9.1
23
39
F50.9
ICD-10 Finland
Eating disorder, unspecified
19.7
9.1
13
7
N05AA01
ATC
chlorpromazine; systemic, rectal
25.4
9.0
12
5
A03FA01
ATC
metoclopramide; systemic, rectal
3.3
9.0
50
185
SPAT1222
SPAT
Counselling/guidance promoting independent living
4.2
8.9
34
92
N05CF02
ATC
zolpidem; oral
3.2
8.9
50
187
TKC20
NOMESCO Finland
Catheterisation of bladder
8.3
8.9
19
25
P06
ICPC
Sleep disturbance
4.1
8.9
35
98
G40.9
ICD-10 Finland
Epilepsy, unspecified
8.9
8.8
18
22
UKC02
NOMESCO Finland
Cystoscopy
4.5
8.8
31
78
F45.0
ICD-10 Finland
Somatization disorder
52.3
8.8
10
*
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
52.3
8.8
10
*
N05AD03
ATC
melperone; systemic
52.3
8.8
10
*
R53
ICD-10 Finland
Malaise and fatigue
3.0
8.7
57
234
S29
ICPC
Skin symptom/complaint other
3.5
8.7
43
146
A02BA02
ATC
ranitidine; systemic
3.5
8.7
43
146
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
17.2
8.7
13
8
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
17.2
8.7
13
8
103
Kela drug reimbursment
Diabetes, insulin-treated
3.3
8.7
47
170
WX892
NOMESCO Finland
Monitored bed care
5.8
8.6
24
46
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.7
8.6
39
123
S18
ICPC
Laceration/cut
2.6
8.6
86
454
J01FF01
ATC
clindamycin; systemic
2.8
8.6
65
294
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
8.5
8.6
18
23
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
28.9
8.6
11
*
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
28.9
8.6
11
*
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
28.9
8.6
11
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.4
8.6
122
780
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
7.7
8.5
19
27
F60.2
ICD-10 Finland
Dissocial personality disorder
+∞
8.4
8
*
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
+∞
8.4
8
*
R52.9
ICD-10 Finland
Pain, unspecified
4.9
8.3
27
62
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
15.3
8.3
13
9
A46
ICD-10 Finland
Erysipelas
4.4
8.3
30
77
T90
ICPC
Diabetes non-insulin dependent
3.5
8.2
40
134
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.6
8.2
23
45
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
34.9
8.2
10
*
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
34.9
8.2
10
*
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
34.9
8.2
10
*
A04
ICPC
Weakness/tiredness general
3.5
8.1
39
129
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
23.1
8.1
11
5
R03BB04
ATC
tiotropium bromide; inhalant
6.2
8.1
21
37
K10.3
ICD-10 Finland
Alveolitis of jaws
5.3
8.1
24
50
N06AA12
ATC
doxepin; systemic
8.3
8.1
17
22
F51.0
ICD-10 Finland
Nonorganic insomnia
3.2
8.0
45
167
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
8.0
35
107
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.7
8.0
36
113
F41.1
ICD-10 Finland
Generalized anxiety disorder
4.6
8.0
27
65
SPAT1240
SPAT
Therapeutic discussion
3.3
8.0
43
154
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.0
7.9
25
56
R42
ICD-10 Finland
Dizziness and giddiness
3.1
7.9
45
169
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
5.4
7.9
23
47
R02
ICPC
Shortness of breath/dyspnoea
3.9
7.9
32
92
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
8.0
7.9
17
23
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.5
7.8
37
121
N04AA02
ATC
biperiden; systemic
15.8
7.8
12
8
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
15.8
7.8
12
8
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
46.8
7.8
9
*
N06AX26
ATC
vortioxetine; oral
4.7
7.8
26
62
X59
ICD-10 Finland
Exposure to unspecified factor
2.9
7.7
53
224
SAA01
NOMESCO Finland
Simple examination of mouth
2.7
7.7
163
1243
K02.1
ICD-10 Finland
Caries of dentine
2.4
7.7
140
986
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
12.5
7.7
13
11
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
12.5
7.7
13
11
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
12.5
7.7
13
11
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.2
7.7
43
159
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
19.3
7.7
11
6
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.1
7.7
44
166
L17
ICPC
Foot/toe symptom/complaint
2.8
7.7
57
251
A01
ICPC
Pain general/multiple sites
4.6
7.6
26
63
P98
ICPC
Psychosis NOS/other
26.1
7.6
10
*
ZXA05
NOMESCO Finland
Left side
2.9
7.6
52
218
A02BC01
ATC
omeprazole; systemic
2.6
7.6
62
290
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.1
7.6
45
171
P01AB01
ATC
metronidazole; oral, rectal
2.4
7.6
93
539
N06AG02
ATC
moclobemide; oral
8.2
7.5
16
21
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
8.2
7.5
16
21
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
4.5
7.5
26
64
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.6
7.5
21
41
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
14.1
7.5
12
9
N06AB08
ATC
fluvoxamine; oral
14.1
7.5
12
9
Z72.8
ICD-10 Finland
Other problems related to lifestyle
83.0
7.5
8
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
83.0
7.5
8
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.2
7.4
22
46
F60.7
ICD-10 Finland
Dependent personality disorder
+∞
7.3
7
*
P28
ICPC
Limited function/disability (P)
16.5
7.3
11
7
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
5.7
7.3
20
38
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.1
7.3
22
47
EBA00
NOMESCO Finland
Extraction of tooth
2.3
7.3
84
472
R33
ICD-10 Finland
Retention of urine
6.5
7.3
18
30
R07.4
ICD-10 Finland
Chest pain, unspecified
2.7
7.3
53
232
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.3
7.2
21
43
SPAT1104
SPAT
Monitoring of emergency patient
5.3
7.2
21
43
Z3229
NOMESCO Finland
Other healthcare associate professional
4.5
7.2
25
62
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.5
7.2
34
111
P19
ICPC
Drug abuse
20.9
7.2
10
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
7.1
59
276
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
7.1
57
264
A02BC02
ATC
pantoprazole; systemic
2.3
7.1
125
850
B18.2
ICD-10 Finland
Chronic viral hepatitis C
14.4
7.0
11
8
183
Kela drug reimbursment
Lamotrigin and topiramate
14.4
7.0
11
8
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
8.8
6.9
14
17
SPAT1307
SPAT
Psychosocial counselling and guidance
3.6
6.9
31
97
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.4
6.9
33
109
J46
ICD-10 Finland
Status asthmaticus
9.8
6.9
13
14
A10AE04
ATC
insulin glargine; parenteral
4.4
6.9
24
60
X58
ICD-10 Finland
Exposure to other specified factors
3.0
6.9
42
164
Z72.2
ICD-10 Finland
Drug use
17.4
6.8
10
6
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
17.4
6.8
10
6
F21
ICD-10 Finland
Schizotypal disorder
41.5
6.8
8
*
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
41.5
6.8
8
*
R52.2
ICD-10 Finland
Other chronic pain
6.3
6.8
17
29
N06AX22
ATC
agomelatine; oral
8.3
6.7
14
18
A07AA09
ATC
vancomycin; oral
23.4
6.7
9
*
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
23.4
6.7
9
*
R96
ICPC
Asthma
4.0
6.7
26
72
K92.0
ICD-10 Finland
Haematemesis
12.8
6.7
11
9
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
12.8
6.7
11
9
F93.89
ICD-10 Finland
Other childhood emotional disorders
12.8
6.7
11
9
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
12.8
6.7
11
9
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.8
6.6
27
78
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.0
6.6
20
43
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
6.1
6.6
17
30
N06BA04
ATC
methylphenidate; oral
6.6
6.6
16
26
G44.2
ICD-10 Finland
Tension-type headache
3.0
6.6
40
154
J01MA12
ATC
levofloxacin; systemic
3.2
6.6
36
129
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.3
6.6
19
39
A10BA02
ATC
metformin; oral
2.8
6.5
43
176
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
5.9
6.5
17
31
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
72.0
6.5
7
*
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
72.0
6.5
7
*
F60.1
ICD-10 Finland
Schizoid personality disorder
72.0
6.5
7
*
Z71.8
ICD-10 Finland
Other specified counselling
2.4
6.5
64
330
C08DA01
ATC
verapamil; systemic
8.6
6.4
13
16
R50.9
ICD-10 Finland
Fever, unspecified
3.1
6.4
36
133
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
11.5
6.4
11
10
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
6.4
97
607
Z2221
NOMESCO Finland
Medical doctor
2.3
6.3
67
356
XKD00
NOMESCO Finland
Uroflowmetry
4.2
6.3
23
60
A28
ICPC
Limited function/disability NOS
3.8
6.3
26
76
F22.0
ICD-10 Finland
Delusional disorder
18.7
6.3
9
5
N05AF01
ATC
flupentixol; systemic
18.7
6.3
9
5
F41.09
ICD-10 Finland
UNS Panic Syndrome
6.1
6.3
16
28
J04AB02
ATC
rifampicin; systemic
+∞
6.3
6
*
N06AX17
ATC
milnacipran; oral
27.6
6.3
8
*
N06AA22
ATC
NA
27.6
6.3
8
*
A41.9
ICD-10 Finland
Sepsis, unspecified
8.1
6.2
13
17
J01EA01
ATC
trimethoprim; systemic
2.4
6.2
56
274
P15
ICPC
Chronic alcohol abuse
7.1
6.2
14
21
R81
ICPC
Pneumonia
9.0
6.1
12
14
A04AA01
ATC
ondansetron; systemic, rectal
4.6
6.1
20
47
R00.0
ICD-10 Finland
Tachycardia, unspecified
6.4
6.1
15
25
G43.3
ICD-10 Finland
Complicated migraine
10.5
6.1
11
11
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.3
6.1
63
328
L08
ICPC
Shoulder symptom/complaint
2.8
6.1
39
158
L15
ICPC
Knee symptom/complaint
2.6
6.0
46
204
G47.3
ICD-10 Finland
Sleep apnoea
2.8
6.0
41
171
S22
ICPC
Nail symptom/complaint
5.4
6.0
17
34
J01MA02
ATC
ciprofloxacin; systemic
2.2
6.0
73
409
NA1AD
NOMESCO Finland
Cervical spine CT examination
7.6
6.0
13
18
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
7.6
6.0
13
18
H03AA01
ATC
levothyroxine sodium; systemic
2.5
6.0
51
241
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
3.0
6.0
35
133
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.3
6.0
21
53
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
39
53
8.74
28.12
2.7
1.6
—
—
—
0
0
(4198724)
19
13
15.91
21.31
2.3
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
63
183
4.43
20.24
1.8
1.6
nmol/l
957.8
1209.9
1.78
49
146
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
124
593
3.52
18.80
3.8
3.2
u/l
28.4
30.0
0.38
117
563
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
127
625
3.46
18.22
6.3
6.3
mmol/l
1.2
1.2
0.20
106
528
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
118
564
3.37
17.60
6.7
5.3
mmol/l
1.2
1.2
0.03
106
528
(3016879) Cocaine [Presence] in Urine
49
132
4.49
17.16
2.7
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
51
142
4.38
17.11
2.9
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
51
143
4.35
16.94
2.8
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
145
799
3.41
16.79
5.7
5.6
umol/l
9.9
10.4
0.21
135
753
(3028300) Cannabinoids [Presence] in Urine
51
145
4.28
16.62
2.9
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
44
114
4.58
16.13
2.7
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
38
88
5.01
15.95
2.9
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
116
576
3.16
15.75
4.3
4.8
g/l
36.9
37.2
0.23
109
552
(3009508) Creatinine [Moles/volume] in Urine
92
401
3.23
15.62
3.3
3.0
mmol/l
7.3
8.2
0.77
78
350
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
104
489
3.15
15.47
3.4
2.7
u/l
46.8
57.1
2.26
94
455
(3007853) Bacteria identified in Skin by Aerobe culture
53
165
3.92
15.17
2.1
1.5
—
—
—
0
0
(3012544) pH of Venous blood
37
88
4.86
15.02
4.2
2.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
43
116
4.37
14.92
4.9
11.2
mmol/l
-0.2
1.1
1.20
34
94
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
105
514
3.00
14.28
2.3
1.7
pmol/l
97.7
101.1
0.26
56
249
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
75
303
3.24
14.28
2.7
1.7
%
1.5
1.4
0.36
64
274
(3027944) Amphetamines [Presence] in Urine
47
144
3.88
13.67
2.9
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
152
966
2.87
11.86
14.6
8.7
e9/l
4.6
3.9
2.19
133
853
(3000991) Gas panel - Venous blood
32
82
4.40
11.76
6.1
6.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
26
56
5.13
11.76
3.8
16.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
45
150
3.52
11.46
2.3
2.0
nmol/l
315.9
404.7
2.31
40
142
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
176
1227
3.21
11.26
8.7
6.6
u/l
79.9
73.5
1.08
164
1146
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
24
52
5.06
10.76
2.6
2.1
%
2.2
1.6
0.93
24
52
(3012095) Magnesium [Moles/volume] in Serum or Plasma
52
197
3.15
10.74
2.0
3.3
mmol/l
0.8
0.8
0.54
47
185
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
114
650
2.57
10.70
2.7
2.2
nmol/l
70.2
73.3
0.45
98
598
(3018418) pH of Serum or Plasma
80
386
2.69
10.57
4.3
3.1
ph
7.4
7.4
0.42
14
80
(3013826) Glucose [Moles/volume] in Serum or Plasma
141
894
2.62
10.52
6.6
4.4
mmol/l
6.8
6.3
1.25
135
800
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
42
144
3.37
10.18
2.9
2.3
u/l
25.9
35.6
0.76
36
118
(3030467) Casts [#/volume] in Urine by Automated count
79
386
2.64
10.11
4.0
2.5
e6/l
0.3
0.2
0.25
61
275
(3013115) Eosinophils [#/volume] in Blood
135
854
2.51
9.88
10.0
5.8
e9/l
0.2
0.2
0.31
119
774
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
15
22
7.25
9.86
25.3
17.0
nmol/l
1628.3
1231.4
0.99
15
22
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
15
22
7.25
9.86
18.5
14.4
nmol/l
995.8
708.1
1.28
15
22
(3018095) Leukocytes [#/volume] in Urine
98
544
2.45
9.45
5.4
3.1
e6/l
51.6
113.4
0.44
69
350
(3006315) Basophils [#/volume] in Blood
130
823
2.43
9.28
8.4
5.4
e9/l
0.0
0.0
0.46
114
738
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
73
359
2.55
9.08
2.1
1.8
mg/l
3.1
2.8
0.46
62
310
(3001604) Monocytes [#/volume] in Blood
129
820
2.39
9.04
8.4
5.4
e9/l
0.6
0.5
1.14
113
734
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
25
65
4.21
8.97
5.5
8.3
%
1.9
1.4
0.66
25
65
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
65
4.21
8.97
3.5
2.4
mmol/l
0.8
1.0
0.09
20
48
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
47
189
2.89
8.63
1.7
2.5
umol/l
8.9
9.0
0.00
33
165
(3019060) Gas panel - Arterial blood
25
67
4.08
8.62
4.7
11.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
79
413
2.43
8.54
4.0
2.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
57
256
2.66
8.47
1.7
1.4
pmol/l
422.2
438.4
0.19
47
230
(3032080) INR in Blood by Coagulation assay
89
492
2.36
8.47
4.7
6.3
inr
1.0
1.1
0.56
30
174
(42870588) Differential panel, method unspecified - Blood
93
525
2.34
8.42
7.8
5.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
77
400
2.43
8.42
4.0
2.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
23
59
4.24
8.39
2.2
1.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
24
65
4.02
8.15
5.4
8.2
%
0.6
0.7
0.62
24
65
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
89
499
2.32
8.13
4.2
2.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
65
317
2.49
8.12
7.5
4.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
81
438
2.35
8.03
4.5
2.6
e6/l
28.9
65.2
0.52
65
320
(3019198) Lymphocytes [#/volume] in Blood
131
868
2.27
7.94
8.3
5.4
e9/l
2.1
2.0
0.99
119
790
(3015377) Calcium [Moles/volume] in Serum or Plasma
84
464
2.31
7.91
2.2
3.1
mmol/l
2.3
2.3
0.50
77
419
(3022096) Basophils/100 leukocytes in Blood
119
762
2.23
7.80
8.7
5.7
%
0.6
0.7
0.42
105
715
(3024928) Oxygen saturation in Venous blood
12
18
7.00
7.69
2.1
3.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
32
110
3.24
7.65
2.0
1.5
mu/l
379.3
310.4
0.50
27
97
(3026782) Osmolality of Urine
58
275
2.51
7.65
3.7
2.3
mosm/kgh2o
502.1
578.5
1.78
51
233
(3019069) Monocytes/100 leukocytes in Blood
121
788
2.20
7.51
9.2
5.9
%
7.7
8.1
0.76
109
748
(3020682) Albumin/Creatinine [Ratio] in Urine
67
343
2.37
7.45
3.7
4.0
mg/mmol
3.4
12.0
1.92
47
223
(3018010) Neutrophils/100 leukocytes in Blood
124
819
2.19
7.38
8.4
5.2
%
57.3
56.5
0.33
112
780
(3006504) Eosinophils/100 leukocytes in Blood
121
792
2.18
7.37
8.7
5.5
%
2.5
2.7
0.63
109
743
(3000494) Fungus identified in Specimen by Culture
43
179
2.74
7.34
1.7
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
64
323
2.39
7.34
3.3
3.4
mg/l
1053.5
292.0
0.33
46
213
(40758558) Short blood count panel - Blood
73
392
2.29
7.24
11.1
6.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
39
4.64
7.09
3.5
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
58
286
2.40
6.97
3.6
2.2
e6/l
6.0
5.7
0.08
53
253
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
180
1406
2.57
6.88
6.1
4.1
pmol/l
14.3
14.4
0.44
169
1310
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
46
207
2.55
6.70
2.2
2.6
mmol/l
2.4
2.4
0.52
41
182
(3002030) Lymphocytes/100 leukocytes in Blood
123
831
2.10
6.66
8.9
5.4
%
28.6
29.6
0.47
111
789
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
46
209
2.52
6.56
2.8
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
27
92
3.21
6.54
1.4
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
50
237
2.44
6.52
5.0
2.7
ng/l
43.4
197.2
0.82
30
142
(3019230) Fractional oxyhemoglobin in Venous blood
10
15
6.94
6.36
2.1
1.3
%
65.7
69.2
—
10
15
(3042936) Bacteria identified in Isolate by Culture
43
194
2.51
6.21
2.0
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
57
295
2.26
6.05
1.7
1.4
nmol/l
17.6
20.5
0.81
49
260
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
35
145
2.68
5.99
2.7
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
52
261
2.30
5.93
2.1
2.7
ng/l
255.5
755.8
2.75
41
210
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
35
146
2.66
5.91
2.8
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
47
226
2.37
5.90
3.6
2.3
e6/l
5.6
3.2
0.38
25
112
(3023410) Appearance of Cerebral spinal fluid
12
24
5.23
5.81
1.5
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
47
230
2.33
5.66
3.4
2.2
e6/l
0.9
1.0
0.09
25
117
(3052851) Hemolysis interference index of Serum or Plasma
14
33
4.46
5.64
5.7
2.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
48
3.76
5.44
1.2
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
82
3.02
5.16
1.9
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
146
1110
1.95
5.05
4.4
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
108
749
1.87
4.93
11.6
8.0
e9/l
0.0
0.0
0.84
86
627
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
15
42
3.76
4.86
2.8
17.3
%
2.3
1.7
0.60
15
37
(3001122) Ferritin [Mass/volume] in Serum or Plasma
122
883
1.86
4.83
3.1
2.6
ug/l
74.5
81.0
0.34
112
838
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
184
1530
2.27
4.83
6.9
4.1
mmol/mol
39.8
37.8
1.54
170
1455
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
86
2.87
4.75
1.9
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
43
3.67
4.70
1.3
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
7
5
14.39
4.60
4.3
2.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
159
1264
1.94
4.57
4.6
3.5
mm/h
9.2
8.7
0.27
144
1182
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
195
1673
2.51
4.56
7.5
4.5
mu/l
1.8
1.7
0.12
184
1579
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
168
1364
1.99
4.49
5.9
2.8
u/l
45.3
41.1
0.43
159
1316
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
79
508
1.87
4.48
4.6
2.7
ng/l
13.5
38.2
1.54
47
253
(3020891) Body temperature
15
45
3.50
4.41
8.1
4.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
56
3.21
4.34
2.4
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
61
365
1.93
4.28
3.4
2.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
150
1186
1.84
4.20
6.2
3.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
16
52
3.24
4.18
1.3
1.3
e6/l
17.5
26.8
—
8
43
(3022313) Gas panel - Capillary blood
16
52
3.24
4.18
4.3
2.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
16
52
3.24
4.18
1.3
1.2
e6/l
2.9
7.2
—
8
40
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
68
425
1.87
4.17
2.6
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
72
465
1.82
3.95
2.8
2.3
—
—
—
0
0
(3019225) pH of Specimen
25
108
2.48
3.93
3.8
3.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
19
72
2.79
3.84
4.1
3.3
mmol/l
24.6
24.9
0.13
19
72
(1616796) Gas panel - Central venous blood
10
25
4.14
3.74
2.8
2.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
311
0.32
3.67
1.2
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
62
391
1.82
3.64
2.3
1.6
mg/l
0.7
0.7
0.27
44
289
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
9
7.99
3.58
2.0
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
204
1835
2.63
3.44
22.7
10.1
mg/l
16.1
19.8
1.39
179
1382
(3004588) Protein electrophoresis panel - Serum or Plasma
16
59
2.85
3.40
1.4
1.3
—
—
—
0
0
(3013512) EKG study
57
359
1.79
3.34
4.9
2.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
25
117
2.28
3.31
3.6
4.3
%
1.2
0.8
—
5
33
(3048689) Calprotectin [Mass/mass] in Stool
46
272
1.87
3.29
2.0
2.3
ug/g
100.7
106.5
0.05
34
208
(3016018) Differential panel - Cerebral spinal fluid
9
19
4.89
3.27
1.4
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
64
420
1.74
3.25
2.0
1.7
mmol/l
1.6
1.4
0.87
57
365
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
189
1668
1.97
3.04
5.9
3.4
mmol/l
6.2
5.7
2.70
178
1558
(36660697) Celiac disease serology panel - Serum
30
157
2.06
3.03
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
35
3.26
2.97
3.6
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
9
6.81
2.88
2.8
2.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
9
6.81
2.88
1.3
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
84
609
1.62
2.88
2.6
2.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
36
206
1.89
2.84
1.3
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
18
4.57
2.82
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
49
311
1.74
2.77
2.2
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
24
3.86
2.70
2.9
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
24
3.86
2.70
2.9
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
12
43
2.89
2.69
1.4
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
187
1664
1.85
2.66
19.0
8.7
ml/min/173m2
95.5
93.1
0.68
150
1328
(3035350) Ketones [Presence] in Urine by Test strip
110
865
1.55
2.59
4.3
3.0
estimate
0.0
0.0
0.00
19
175
(3005570) Glucose [Moles/volume] in Urine
7
16
4.48
2.49
7.1
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
21
3.91
2.49
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
51
340
1.65
2.39
1.3
1.3
iu/ml
87.4
31.8
—
10
115
(3000330) Specific gravity of Urine by Test strip
15
65
2.40
2.37
4.4
2.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
22
113
2.05
2.35
1.7
2.2
%
1.8
1.6
0.34
17
107
(3019150) Specific gravity of Urine by Refractometry
55
376
1.62
2.34
3.1
3.0
kg/l
1.0
1.0
—
5
55
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
43
276
1.69
2.32
2.2
1.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
13
4.71
2.28
1.0
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
7
18
3.98
2.27
1.0
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
9
29
3.19
2.25
1.4
1.1
g/l
0.0
0.0
—
9
29
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
9
29
3.19
2.25
1.4
1.1
g/l
0.0
0.0
—
9
29
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
27
152
1.89
2.24
2.1
2.5
u/l
5471.5
2198.4
—
6
73
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
20
101
2.08
2.24
2.3
2.7
mmol/l
1.2
1.2
0.08
15
93
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
36
2.86
2.23
1.4
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
9
5.65
2.22
6.2
3.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
11
42
2.70
2.22
4.5
15.8
mmol/l
1.5
1.2
0.48
11
34
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
36
223
1.74
2.21
2.0
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
74
2.25
2.20
3.1
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
55
2.45
2.16
3.2
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
14
4.37
2.16
1.0
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
14
4.37
2.16
1.7
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
25
3.28
2.11
1.4
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
107
862
1.47
2.11
5.4
4.2
estimate
0.0
0.0
0.50
23
176
(3009261) Glucose [Presence] in Urine by Test strip
108
872
1.47
2.10
4.0
3.0
estimate
0.0
0.0
0.00
23
171
(3007164) IgA [Mass/volume] in Serum or Plasma
58
412
1.55
2.08
1.7
1.3
g/l
2.3
2.2
0.28
36
272
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
20
3.58
2.07
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
15
4.08
2.05
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
15
4.08
2.05
2.0
2.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
9
32
2.89
2.02
1.4
1.1
g/l
0.0
0.0
—
9
32
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
16
77
2.16
2.02
1.4
2.3
ug/l
9.4
6.8
—
9
68
(3022145) Colonoscopy Study observation
28
166
1.79
1.99
1.1
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
21
3.41
1.98
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
16
78
2.13
1.96
2.4
2.4
e9/l
80.6
71.3
—
10
56
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
9
33
2.80
1.95
1.4
1.3
g/l
0.0
1.0
—
9
33
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
39
2.64
1.95
1.3
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
182
0.42
1.92
1.5
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
271
0.48
1.91
1.1
1.5
—
—
—
0
0
(3015736) pH of Urine
86
675
1.45
1.89
4.1
2.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
63
465
1.50
1.89
1.6
1.3
u/ml
2.0
1.9
0.04
12
139
(3025130) Human papilloma virus identified in Specimen
11
46
2.46
1.88
1.5
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
60
788
0.67
1.86
2.6
2.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
17
3.60
1.85
1.3
2.8
—
—
—
0
0
(4027681)
5
12
4.24
1.83
1.2
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
7
23
3.11
1.81
1.1
1.3
mu/l
208.9
53.5
—
7
18
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
29
180
1.70
1.78
2.7
2.0
%
21.0
23.9
0.39
23
159
(40768804) Tissue Pathology biopsy report
88
701
1.43
1.76
2.0
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
111
1.88
1.75
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
30
2.73
1.74
1.4
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
13
3.91
1.72
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
70
2.07
1.63
1.7
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
157
0.43
1.62
1.3
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
19
107
1.85
1.60
3.4
2.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
19
107
1.85
1.60
3.5
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
20
3.05
1.59
1.3
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
20
3.05
1.59
1.3
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
18
100
1.87
1.58
1.2
1.1
titre
—
132.2
—
0
5
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
52
386
1.46
1.50
3.0
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
38
2.43
1.47
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
320
0.59
1.47
1.6
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
28
2.55
1.46
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
46
335
1.47
1.46
1.3
1.3
u/ml
1.0
10.7
3.12
14
151
(3022806) Fractional oxyhemoglobin in Capillary blood
5
16
3.17
1.44
1.2
1.4
%
92.1
90.5
—
5
16
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
22
2.77
1.44
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
96
1.84
1.43
2.4
2.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
257
0.55
1.41
1.4
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
23
2.65
1.37
1.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
39
278
1.49
1.37
1.5
1.4
titre
213.3
432.1
—
6
61
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
17
2.98
1.36
1.2
1.5
—
—
—
0
0
(4010399)
17
98
1.80
1.35
1.5
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
41
0.00
1.32
0.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
28
187
1.57
1.32
1.8
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
157
0.49
1.31
1.3
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
44
2.09
1.28
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
35
2.33
1.28
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
45
2.04
1.25
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
57
445
1.38
1.24
5.6
4.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
20
125
1.66
1.22
1.6
1.3
iu/l
12.2
19.4
0.60
14
103
(3028192) IgG subclass 2 [Mass/volume] in Serum
5
19
2.67
1.22
1.2
1.5
g/l
2.0
3.1
—
5
11
(3027135) IgG subclass 1 [Mass/volume] in Serum
5
19
2.67
1.22
1.2
1.5
g/l
5.8
6.1
—
5
11
(3024139) IgG subclass 3 [Mass/volume] in Serum
5
19
2.67
1.22
1.2
1.5
g/l
0.3
0.4
—
5
11
(4062490)
5
19
2.67
1.22
1.2
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
203
1933
1.69
1.20
15.4
8.2
u/l
29.1
27.6
0.40
198
1875
(40761536) Microorganisms panel - Urine sediment
24
161
1.55
1.12
4.0
3.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
21
2.41
1.09
1.0
1.4
nmol/l
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
59
1.91
1.09
1.5
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
154
1.55
1.09
6.7
5.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
10
52
1.97
1.08
1.4
1.2
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
7
34
2.09
1.04
4.0
1.8
kpa
8.5
9.4
—
7
34
(3013290) Carbon dioxide [Partial pressure] in Blood
7
34
2.09
1.04
4.0
1.8
kpa
5.2
5.2
—
7
34
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
47
1.95
1.03
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
53
1.93
1.03
2.7
2.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
143
0.54
0.97
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
143
0.54
0.97
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
143
0.54
0.97
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
143
0.54
0.97
1.1
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
120
0.49
0.96
1.3
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
18
118
1.57
0.94
1.6
1.2
—
30.5
—
0
5
(3029937) Albumin [Presence] in Urine by Test strip
56
458
1.30
0.89
4.1
3.2
estimate
0.0
0.0
0.50
23
177
(3019832) Treponema pallidum Ab [Presence] in Serum
52
421
1.31
0.89
2.0
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
115
0.51
0.85
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
115
0.51
0.85
1.2
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
31
1.96
0.85
1.0
4.9
—
914.0
—
0
5
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
97
1.59
0.84
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
62
519
1.27
0.82
1.9
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
63
529
1.27
0.82
3.2
1.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
34
1.79
0.77
1.0
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
38
301
1.32
0.76
3.6
3.3
ug/l
0.8
1.6
3.52
31
277
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
23
168
1.41
0.75
5.4
3.2
%
28.6
31.4
0.58
18
112
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
55
1.66
0.74
2.8
1.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
42
1.69
0.69
2.0
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
78
1.57
0.67
1.8
1.4
—
—
—
0
0
(3000492) Spirometry study
24
181
1.37
0.66
1.3
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
29
1.74
0.64
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
149
1578
0.83
0.62
4.5
3.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
105
1.46
0.62
1.6
1.5
miu/ml
152.2
322.4
—
6
60
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
54
1.50
0.58
1.4
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
184
1767
1.26
0.57
5.1
3.8
mmol/l
2.8
2.9
1.18
172
1665
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
88
0.56
0.57
2.8
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
107
1.43
0.57
4.6
2.0
ml/min/173m2
80.0
75.8
—
8
44
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
55
1.47
0.56
1.4
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
39
1.55
0.53
1.3
2.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
182
1752
1.23
0.51
4.8
3.6
mmol/l
4.6
4.8
2.69
169
1658
(3002256) Pathology report gross observation
25
199
1.29
0.50
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
57
646
0.84
0.50
1.7
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
109
0.63
0.50
2.3
2.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
31
1.63
0.43
1.4
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
31
1.63
0.43
1.2
1.6
g/l
0.4
0.7
—
5
23
(4034850)
8
56
1.44
0.43
14.8
5.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
56
1.44
0.43
1.4
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
57
1.42
0.42
2.3
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
21
259
0.79
0.42
2.0
1.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
0.9
—
0
15
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
4.0
—
81.4
—
0
16
(3041806) Other cells [#/volume] in Blood by Manual count
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
17
0.00
0.41
0.0
1.2
—
1.1
—
0
7
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
181
0.76
0.40
1.4
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
11
80
1.39
0.39
5.0
2.0
e6/l
0.1
0.1
0.05
11
75
(3003888) Timothy IgE Ab [Units/volume] in Serum
5
36
1.40
0.38
1.2
1.1
u/ml
0.2
6.4
—
5
24
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
119
1.28
0.32
1.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
92
862
1.12
0.31
4.2
4.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
17
140
1.23
0.28
5.8
2.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
65
1.24
0.27
1.5
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
67
1.20
0.26
1.7
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
38
1.32
0.23
5.2
4.5
%
63.4
56.8
—
5
38
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
38
1.32
0.23
5.2
4.3
e9/l
4.0
4.1
—
5
38
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
172
1679
1.11
0.23
4.0
3.3
mmol/l
1.5
1.3
3.72
156
1585
(3009542) Hematocrit [Volume Fraction] of Blood
184
1803
1.13
0.23
27.2
10.6
%
40.1
40.9
0.83
139
1512
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
15
177
0.84
0.22
2.9
2.3
ug/l
0.6
0.7
—
7
87
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
2.3
—
0
12
(40768800) Prostate Pathology biopsy report
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(4035726)
14
117
1.21
0.21
1.4
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
13
0.00
0.21
0.0
1.5
—
5.5
—
0
13
(3029075) Extractable nuclear Ab panel - Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
14
0.00
0.20
0.0
1.6
—
1.8
—
0
8
(40768795) Lymph node Pathology biopsy report
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
72
685
1.08
0.17
4.1
3.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
56
531
1.07
0.14
3.6
2.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
8
97
0.82
0.14
5.1
2.5
u/ml
21.6
43.4
—
8
92
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
113
1.16
0.13
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
54
518
1.06
0.10
2.2
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
42
439
0.95
0.08
2.1
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
61
0.82
0.08
1.0
1.3
—
9.9
—
0
11
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
176
1742
1.05
0.07
4.7
3.6
mmol/l
1.3
1.5
10.05
164
1646
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
22
233
0.94
0.06
3.5
3.2
%
32.9
22.2
—
6
74
(3008898) HLA-B27 [Presence]
13
119
1.10
0.06
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
199
1978
1.07
0.05
21.4
9.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
170
1686
1.04
0.05
31.3
12.4
g/l
333.1
333.7
0.40
170
1677
(3010813) Leukocytes [#/volume] in Blood
209
2099
0.91
0.04
35.7
15.0
e9/l
7.3
6.6
6.30
204
2054
(3026493) Urate [Moles/volume] in Serum or Plasma
38
373
1.02
0.01
2.2
2.1
umol/l
329.0
6974.5
1.76
32
338
(3025941) Bacteria identified in Stool by Culture
12
119
1.01
0.00
1.8
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
173
0.98
0.00
1.4
1.3
iu/ml
302.4
126.6
—
5
69
(1002224) Polysomnography panel
10
103
0.97
0.00
1.2
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
6.8
—
0
8
(3034426) Prothrombin time (PT)
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
205.6
—
0
7
(40768446) Kidney Pathology biopsy report
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
5
0.00
0.00
0.0
2.0
—
7.0
—
0
5
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
95
0.95
0.00
1.1
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
8.9
—
0
7
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
70
1.00
0.00
1.3
2.8
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.2
—
9.6
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
23.3
—
0
6
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
81.3
—
0
6
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_PERSOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_PERSOTH | 3.96 [2.86, 5.48] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.546 |
During the follow-up period (1.1.1998 — 31.12.2019), 122 out of 874 females with F5_PERSOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_PERSOTH | 3.707 [2.77, 4.95] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 154 out of 864 males with F5_PERSOTH died.
Mortality risk
Mortality risk for people of age
years, who have F5_PERSOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.438% | 0.701% |
| 5 | 2.464% | 4.344% |
| 10 | 5.706% | 9.585% |
| 15 | 10.864% | 17.3% |
| 20 | 18.266% | 27.732% |
Relationships between endpoints
↥Index endpoint: F5_PERSOTH – Other and unspecified disorders of adult personality and behaviour
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data